Article

Remarkable response to pralsetinib in an advanced pulmonary sarcomatoid carcinoma patient harboring a KIF5B-RET rearrangement: A case report

2022-07-07

Abstract excerpt

<h4>Background: </h4> Pulmonary sarcomatoid carcinoma (PSC) is a rare and unconventional non-small-cell lung cancer (NSCLC) that appears to be more aggressive, with a poorer prognosis and response to conventional treatment. Approximately 30% of PSCs have potentially targetable genomic alterations, but few studies have involved RET gene fusions, and corresponding targeted therapies are lacking. Case presentation:...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1269f5c9-a6ed-5fdd-83d1-ac22802396a5
DOI: 10.21203/rs.3.rs-1807980/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Remarkable response to pralsetinib in an advanced pulmonary sarcomatoid carcinoma patient harboring a KIF5B-RET rearrangement: A case reportDOI 10.21203/rs.3.rs-1807980/v1Read

[Detection of novel driver mutations in liquid biopsy: case report of a RET-positive lung adenocarcinoma treated with pralsetinib.]Semantic proximity Read

Pralsetinib-Induced Interstitial Pneumonitis in a Patient with Metastatic Pulmonary Spindle Cell Carcinoma Harboring RET fusion: A Case ReportSemantic proximity Read

Lung cancer treated abroad with receptor tyrosine kinase inhibitor.Semantic proximity Read

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinomaSemantic proximity Read

Molecular pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangementSemantic proximity Read

Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implicationsSemantic proximity Read

RET-rearranged non-small-cell lung cancer and therapeutic implications.Semantic proximity Read

Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients.Semantic proximity Read

RET Fusion-Positive Lung Adenocarcinoma: Partner-Specific Clinicopathological Characteristics, Co-Mutation Profiles, and Implications for Targeted and Immunotherapy.Semantic proximity Read

[Advances in the Treatment of RET Fusion-positive Advanced Non-small Cell Lung Cancer].Semantic proximity Read

A case of neoadjuvant targeted therapy with pralsetinib for locally advanced lung adenocarcinoma with RET fusion mutation.Semantic proximity Read

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma.Semantic proximity Read